文献速递流行病学与生物统计医学教育与科研方法

二级电子来源对COVID-19干预研究识别的敏感性良好

Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19.
PubMed 文献 · J Clin Epidemiol · 2021-09-20

该研究评估了Cochrane COVID-19研究注册库和L•OVE COVID-19平台两个二级电子来源识别COVID-19干预研究的敏感性,以COVID-NMA平台等构成的参考标准为对照,检索截止2020年9月7日。共纳入680份报告,Cochrane注册库对RCT报告、RCT方案和观察性研究的敏感性分别为88%、90%和82%,L•OVE平台均为100%。结论认为这些平台可作为替代逐一检索各来源的可行筛选方案。

要点

  • Cochrane COVID-19注册库识别RCT报告的敏感性为88%。
  • L•OVE平台识别RCT报告和方案的敏感性均为100%。
  • 二级电子来源可替代逐一检索各来源进行筛选。

核心结论

  • Cochrane COVID-19研究注册库和L•OVE平台对COVID-19干预研究具有良好敏感性,可作为替代逐一检索各来源的可行筛选方案。

研究设计与样本

  • 研究评估两个二级电子来源的敏感性,参考标准由COVID-NMA平台、两项主要活系统评价纳入报告或任一二级来源识别的报告构成。
  • 共识别680份报告,包括91份RCT报告、97份RCT方案和492份观察性研究报告,检索截止2020年9月7日。

主要发现

  • Cochrane COVID-19研究注册库识别了88%[95%CI 79-94]的RCT报告、90%[95%CI 82-95]的RCT方案和82%[95%CI 78-85]的观察性研究报告。
  • L•OVE平台识别了100%[95%CI 97-100]的RCT报告和RCT方案,以及100%[95%CI 99-100]的观察性研究报告。

临床怎么用

  • 在COVID-19相关证据筛选中,可优先使用Cochrane COVID-19研究注册库或L•OVE平台,以提高筛选效率并减少逐一检索各来源的工作量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the sensitivity of two secondary electronic sources of COVID-19 studies: 1) the Cochrane COVID-19 Study Register (https://covid-19.cochrane.org/); and, 2) the Living Overview of the Evidence (L•OVE) COVID-19 platform (https://iloveevidence.com/). STUDY DESIGN AND SETTING: We identified reports of randomized controlled trials (RCTs) and observational studies (OS) assessing preventive interventions or treatment for COVID-19. The reference standard comprised all reports included in the COVID-NMA platform (covid-nma.com), in two major living systematic reviews of RCTs assessing pharmacologic treatment of COVID-19, or identified in either of the two secondary sources evaluated. The search for all sources was conducted through September 7, 2020. Our primary outcome was the proportion of the reports included in the reference standard that were identified by each secondary source. RESULTS: We identified 680 reports, 91 RCT reports, 97 RCT protocols, and 492 OS reports. The Cochrane COVID-19 Study Register identified 88% [95% confidence interval, 79-94] of the RCT reports, 90% [82-95] of the RCT protocols, and 82% [78-85] of the OS reports. The L•OVE platform identified 100% [97-100] of the RCT reports and RCT protocols and 100% [99-100] of the OS reports. CONCLUSION: These platforms proved to be a viable screening alternative to searching every individual source.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Pierre O, Riveros C, Charpy S, et al. Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19. J Clin Epidemiol. 2021. PMID: 34555426. doi:10.1016/j.jclinepi.2021.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。